MedTrace Logo

Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

NCT04329871 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-04-02

No results posted yet for this study

Summary

Analyze the Medtronic 670g pump on glycemic control

Conditions

  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • Metabolic Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Barry S Horowitz, MD · Metabolic Research Institute, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-24
Primary Completion
2021-03-23
Completion
2021-03-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04329871 on ClinicalTrials.gov